دورية أكاديمية

Reproductive Endocrinologists’ Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers

التفاصيل البيبلوغرافية
العنوان: Reproductive Endocrinologists’ Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers
المؤلفون: Goetsch, Allison L., Wicklund, Catherine, Clayman, Marla L., Woodruff, Teresa K.
المساهمون: National Institutes of Health, National Institute of Child Health and Human Development
المصدر: Journal of Genetic Counseling ; volume 25, issue 3, page 561-571 ; ISSN 1059-7700 1573-3599
بيانات النشر: Wiley
سنة النشر: 2015
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
الوصف: Genetic counselors believe fertility preservation and preimplantation genetic diagnosis (PGD) discussions to be a part of their role when counseling BRCA1/2 mutation‐positive patients. This study is the first to explore reproductive endocrinologists’ (REI) practices and attitudes regarding involvement of genetic counselors in the care of BRCA1/2 mutation carriers seeking fertility preservation and PGD. A survey was mailed to 1000 REIs from Reproductive Endocrinology & Infertility (SREI), an American Society for Reproductive Medicine (ASRM) affiliate group. A 14.5 % response rate was achieved; data was analyzed using SPSS software. The majority of participating REIs were found to recommend genetic counseling to cancer patients considering fertility preservation (82 %) and consult with a genetic counselor regarding PGD for hereditary cancer syndromes (92 %). Additionally, REIs consult genetic counselors regarding PGD patient counseling (88 %), genetic testing (78 %), and general genetics questions (66 %). Two areas genetic counselors may further aid REIs are: elicitation of family history, which is useful to determine fertility preservation and PGD intervention timing (32 % of REIs utilize a cancer family history to determine intervention timing); and, interpretation of variants of uncertain significance (VOUS) as cancer panel genetic testing becomes more common (36 % of REIs are unfamiliar with VOUS). Given our findings, the Oncofertility Consortium® created an online resource for genetic counselors focused on fertility preservation education and communication strategies.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s10897-015-9908-7
DOI: 10.1007/s10897-015-9908-7.pdf
DOI: 10.1007/s10897-015-9908-7/fulltext.html
الإتاحة: https://doi.org/10.1007/s10897-015-9908-7Test
حقوق: http://onlinelibrary.wiley.com/termsAndConditions#vorTest ; http://www.springer.com/tdmTest
رقم الانضمام: edsbas.C49D70D7
قاعدة البيانات: BASE